问题 › AI正在改变我们所在行业 › 专业服务
问题不在于AI能做什么。而在于你的哪些业务会变得更便宜,让客户或竞争对手自己来做。 对专业服务公司来说更难的地方在于结构问题:合伙人薪酬合理地激励人们<em>不</em>去销售公司内利润率最高的产品。因此任何可信的答案都必须同时考虑计费利用率和实现率,而这正是大多数内部分析停止的地方,因为这两者存在于不同系统中。
问题不在于AI能做什么。而在于你的哪些业务会变得更便宜,让客户或竞争对手自己来做。 对专业服务公司来说更难的地方在于结构问题:合伙人薪酬合理地激励人们不去销售公司内利润率最高的产品。因此任何可信的答案都必须同时考虑计费利用率和实现率,而这正是大多数内部分析停止的地方,因为这两者存在于不同系统中。
大多数AI战略讨论从能力开始,却无处着落,因为能力不是决定结果的变量。变量是,你收费的计费工作是否会变得大幅更便宜,让竞争对手或客户自己生产。
这需要逐个业务回答。对每条收入线:计费工时中自动化占比多少,你的价格有多少由工时以外因素支撑,以及可信竞争对手多久能达到同样的实现率和业务利润率。
通常发现暴露的业务线正是盈利的那些,因为高利润工作通常是信息工作。应对很少是更快采用工具,而是把收费内容转向自动化让其更有价值而非更无价值的方向,否则合伙人薪酬仍会激励人们不去销售利润率最高的产品。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 利用率持平但同一业务实现率下降
✓ 客户质疑同样的交付物为何仍需相同计费工时
✓ 新公司以你业务毛利率的一小部分定价同类业务
通常会让情况更糟的做法。 采用工具却不改变收费内容,这同时降低计费利用率和价格,利润率维持原状。
It is for you if you run or finance a professional services firm and the pressure is showing up as price, not as lost deals. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家专业服务公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Re-align partner economics so the $85K diagnostic becomes the highest-compensated path to the $410K implementation.
The leak it closes. Partner-level incentive leakage that currently diverts 25% of diagnostic-eligible opportunities back to T&M work
The assumption it rests on. 15-of-22 partners approve compensation redesign within 60 days — the engine put the probability at 0.7.
| Investment required | $700K total over 36 months — $200K annual incentive pool × 3 years + $100K legal and change-management cost |
| Expected return | 3.4× cash-on-cash over 36 months (NPV $2.4M / $700K investment) on $58.0M current revenue base |
| Revenue, year 1 | +$1.2M incremental diagnostic and implementation revenue (15 additional diagnostics × $85K + 12 conversions × $410K) |
| Revenue, year 2 | +$2.4M cumulative incremental revenue |
| Revenue, year 3 | +$3.7M cumulative incremental revenue |
| Exit criteria | Terminate this move and revert to legacy compensation if (a) fewer than 12-of-22 partners approve redesign by Day 60, or (b) any top-3 account issues an RFP within 90 days of announcement, or (c) diagnostic-to-implementation conversion falls below 10-of-19 by December 31, 2026. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to AI Horizon, one of 29 engagements the platform runs. For 专业服务公司 it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
通常先内部使用正确,因为这能在对客户承诺前先产生自身经济证据。除非竞争对手已重置客户预期,此时内部效率来得太晚。
按价格判断,而非公告。当你销售的产出市场价格开始下跌时,颠覆已到,无论技术能展示什么。
小公司通常有优势,能快速改变收费内容。关键动作是重新定位,这对你来说比有大量基盘要保护的 incumbents 更便宜。
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית